MedPath
FDA Product

Lamotrigine

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Lamotrigine

82868-005

Regulatory Information

82868-005

ANDA077633

C73584

August 15, 2023

USA

These highlights do not include all the information needed to use LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS and LAMOTRIGINE TABLETS FOR ORAL SUSPENSION. LAMOTRIGINE tablets, for oral use LAMOTRIGINE tablets for oral suspension Initial U.S. Approval: 1994

HUMAN PRESCRIPTION DRUG LABEL

1

Company Information

036986393

Active Ingredients

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

SODIUM STARCH GLYCOLATE TYPE A POTATO

Code: 5856J3G2A2

Class Code: IACT

LACTOSE MONOHYDRATE

Code: EWQ57Q8I5X

Class Code: IACT

LAMOTRIGINE

Quantity: 100 mg in 1 1

Code: U3H27498KS

Class Code: ACTIB

POVIDONE

Code: FZ989GH94E

Class Code: IACT

CELLULOSE, MICROCRYSTALLINE

Code: OP1R32D61U

Class Code: IACT

Active Moieties

LAMOTRIGINE

Code: U3H27498KS

© Copyright 2025. All Rights Reserved by MedPath